PRAMOXINE HYDROCHLORIDE HYDROCORTISONE ACETATE

PRAMOXINE HYDROCHLORIDE HYDROCORTISONE ACETATE was reported 810 times

PRAMOXINE HYDROCHLORIDE HYDROCORTISONE ACETATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VACCINATION SITE NERVE DAMAGE 1 0.3333
1 SALPINGO-OOPHORECTOMY UNILATERAL 6 0.0545
2 BLOOD ALUMINIUM INCREASED 2 0.0225
3 RECTAL SPASM 5 0.0216
4 NEUROPROSTHESIS IMPLANTATION 3 0.0216
5 CONGENITAL MITRAL VALVE STENOSIS 1 0.0208
6 DEVICE DISPENSING ISSUE 1 0.0159
7 PULPLESS TOOTH 1 0.0141
8 DECREASED GAIT VELOCITY 2 0.0119
9 ARTERIOVENOUS FISTULA OCCLUSION 2 0.0114
10 MIXED INCONTINENCE 1 0.0110
11 SINUSITIS FUNGAL 8 0.0100
12 CONGENITAL AORTIC STENOSIS 2 0.0099
13 SPINAL SYNOVIAL CYST 1 0.0095
14 UNIVENTRICULAR HEART 1 0.0093
15 SUPERIOR VENA CAVAL OCCLUSION 1 0.0079
16 PRODUCT LEAKAGE 44 0.0078
17 ADENOMATOUS POLYPOSIS COLI 1 0.0071
18 LITHIASIS 2 0.0066
19 MENINGOCELE 1 0.0064
20 ANAL INJURY 1 0.0058
21 INTESTINAL MUCOSAL HYPERTROPHY 1 0.0055
22 MYCOBACTERIUM TEST POSITIVE 1 0.0049
23 FEMALE GENITAL TRACT FISTULA 8 0.0047
24 TARSAL TUNNEL SYNDROME 1 0.0045
25 PROTEUS TEST POSITIVE 1 0.0045
26 INCISION SITE HAEMATOMA 1 0.0043
27 PLEURAL INFECTION 1 0.0043
28 APPLICATION SITE HYPOAESTHESIA 1 0.0043
29 PARANASAL CYST 1 0.0041
30 INCISION SITE DISCHARGE 1 0.0040
31 ANORECTAL DISCOMFORT 21 0.0039
32 AORTA HYPOPLASIA 1 0.0038
33 SPUTUM INCREASED 8 0.0037
34 MERYCISM 1 0.0035
35 DOUBLE OUTLET RIGHT VENTRICLE 1 0.0034
36 POOR DENTAL CONDITION 1 0.0034
37 PLASMA CELL LEUKAEMIA 2 0.0033
38 HAEMORRHOIDS THROMBOSED 1 0.0033
39 INCISION SITE SWELLING 1 0.0033
40 PERSISTENT FOETAL CIRCULATION 2 0.0033
41 SMOKE SENSITIVITY 1 0.0032
42 DEVICE DELIVERY SYSTEM ISSUE 85 0.0031
43 MICROCYTIC ANAEMIA 6 0.0029
44 LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 1 0.0029
45 MULTIPLE SYSTEM ATROPHY 1 0.0028
46 GASTROINTESTINAL MICROORGANISM OVERGROWTH 1 0.0028
47 RESPIRATORY SYMPTOM 8 0.0028
48 PRODUCT DISPENSING ISSUE 12 0.0028
49 PRODUCT DESIGN ISSUE 2 0.0028
50 NAIL INFECTION 4 0.0028
51 CHRONIC LEFT VENTRICULAR FAILURE 1 0.0028
52 HEART VALVE STENOSIS 1 0.0028
53 DIABETIC GASTROPARESIS 1 0.0027
54 MEDIASTINAL DISORDER 1 0.0027
55 NASAL TURBINATE HYPERTROPHY 1 0.0027
56 EMBOLISM VENOUS 8 0.0026
57 PRODUCT DELIVERY MECHANISM ISSUE 14 0.0026
58 DIASTOLIC DYSFUNCTION 8 0.0026
59 DEPENDENCE ON RESPIRATOR 1 0.0025
60 ANKYLOGLOSSIA CONGENITAL 1 0.0025
61 INCISION SITE IMPAIRED HEALING 1 0.0025
62 PERSISTENT DEPRESSIVE DISORDER 1 0.0025
63 MANUFACTURING MATERIALS ISSUE 1 0.0025
64 PHLEBITIS SUPERFICIAL 1 0.0024
65 FRACTURE DISPLACEMENT 1 0.0023
66 POUCHITIS 2 0.0023
67 ACROCHORDON 3 0.0023
68 PHONOPHOBIA 1 0.0022
69 CHRONIC SINUSITIS 8 0.0021
70 WRONG SCHEDULE 2 0.0021
71 PLICATED TONGUE 1 0.0021
72 COARCTATION OF THE AORTA 2 0.0021
73 PILONIDAL CYST 1 0.0020
74 DRUG DELIVERY SYSTEM ISSUE 4 0.0020
75 INTRAOCULAR LENS IMPLANT 1 0.0020
76 CONGENITAL HYDROCEPHALUS 1 0.0020
77 RIGHT ATRIAL DILATATION 1 0.0020
78 ANAL PRURITUS 4 0.0019
79 HYPERTENSIVE URGENCY 1 0.0018
80 PERIRECTAL ABSCESS 2 0.0018
81 BRAIN SCAN ABNORMAL 1 0.0018
82 SUSPECTED PRODUCT TAMPERING 1 0.0018
83 PERFUME SENSITIVITY 1 0.0018
84 EUSTACHIAN TUBE DYSFUNCTION 1 0.0017
85 IRON DEFICIENCY ANAEMIA 16 0.0017
86 DEVICE DISPENSING ERROR 2 0.0017
87 URETHRAL PAIN 1 0.0017
88 BICUSPID AORTIC VALVE 1 0.0017
89 RECTAL DISCHARGE 6 0.0016
90 NASAL POLYPS 8 0.0016
91 RECTAL TENESMUS 2 0.0016
92 HYPERPARATHYROIDISM SECONDARY 4 0.0016
93 ANAL INFLAMMATION 1 0.0016
94 TRACHEO-OESOPHAGEAL FISTULA 1 0.0016
95 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 1 0.0015
96 HYPOPLASTIC LEFT HEART SYNDROME 1 0.0015
97 RED CELL DISTRIBUTION WIDTH INCREASED 6 0.0014
98 ALCOHOL INTOLERANCE 1 0.0014
99 NASAL INJURY 1 0.0014
100 CALCULUS URETERIC 1 0.0014
101 OBSTRUCTIVE SLEEP APNOEA SYNDROME 2 0.0014
102 PULMONARY ARTERY STENOSIS CONGENITAL 1 0.0014
103 NORMOCYTIC ANAEMIA 2 0.0014
104 HAEMORRHOIDS 26 0.0013
105 REBOUND ACID HYPERSECRETION 4 0.0013
106 REFLUX OESOPHAGITIS 1 0.0013
107 QRS AXIS ABNORMAL 1 0.0013
108 TRANSPOSITION OF THE GREAT VESSELS 1 0.0013
109 TRICUSPID VALVE INCOMPETENCE 10 0.0013
110 HAEMORRHOIDAL HAEMORRHAGE 6 0.0012
111 BALANOPOSTHITIS 1 0.0012
112 MUCOUS STOOLS 6 0.0012
113 TWIN PREGNANCY 1 0.0012
114 FRACTURE DELAYED UNION 1 0.0012
115 DEVICE LEAKAGE 51 0.0012
116 PUPIL FIXED 2 0.0012
117 GENITAL BURNING SENSATION 1 0.0012
118 ENDOCRINE OPHTHALMOPATHY 1 0.0012
119 URGE INCONTINENCE 1 0.0011
120 GASTROINTESTINAL FISTULA 1 0.0011
121 DIVERTICULUM 8 0.0011
122 ADENOCARCINOMA GASTRIC 1 0.0011
123 ARNOLD-CHIARI MALFORMATION 1 0.0010
124 COR PULMONALE 1 0.0010
125 ULNA FRACTURE 1 0.0010
126 ANORECTAL DISORDER 2 0.0010
127 PROCTALGIA 6 0.0009
128 PRODUCT CONTAINER ISSUE 8 0.0009
129 SOFT TISSUE DISORDER 1 0.0009
130 CRYPTORCHISM 1 0.0009
131 CATHETER RELATED COMPLICATION 1 0.0009
132 STRESS AT WORK 1 0.0009
133 PUPILS UNEQUAL 1 0.0009
134 PELVIC ABSCESS 1 0.0009
135 ADMINISTRATION SITE PAIN 1 0.0009
136 DENTAL OPERATION 2 0.0008
137 PRODUCT QUALITY ISSUE 110 0.0008
138 MALIGNANT MELANOMA IN SITU 1 0.0008
139 NASAL PRURITUS 1 0.0008
140 BREECH PRESENTATION 1 0.0008
141 EMPHYSEMA 8 0.0008
142 PRODUCT STORAGE ISSUE 3 0.0008
143 LEFT ATRIAL DILATATION 1 0.0008
144 BOWEL MOVEMENT IRREGULARITY 6 0.0008
145 LACTOSE INTOLERANCE 2 0.0008
146 HIATUS HERNIA 10 0.0008
147 ADJUSTMENT DISORDER 1 0.0008
148 SINUS ARRHYTHMIA 1 0.0008
149 ANAEMIA POSTOPERATIVE 1 0.0008
150 INTESTINAL DILATATION 1 0.0007
151 PRODUCT PACKAGING ISSUE 7 0.0007
152 CLUSTER HEADACHE 1 0.0007
153 DRUG SPECIFIC ANTIBODY 1 0.0007
154 RENAL ARTERY STENOSIS 1 0.0007
155 OBSTRUCTIVE AIRWAYS DISORDER 8 0.0007
156 PRODUCT EXPIRATION DATE ISSUE 1 0.0007
157 PROCTITIS 2 0.0007
158 HYSTERECTOMY 6 0.0007
159 HYPERTONIC BLADDER 2 0.0007
160 PULMONARY SEPSIS 1 0.0007
161 PREGNANCY ON CONTRACEPTIVE 1 0.0007
162 PULMONARY VALVE INCOMPETENCE 1 0.0007
163 ANKLE OPERATION 1 0.0007
164 ADHESION 1 0.0007
165 EPICONDYLITIS 1 0.0007
166 ORAL MUCOSAL EXFOLIATION 1 0.0007
167 MOUTH INJURY 1 0.0007
168 MYOCLONIC EPILEPSY 1 0.0007
169 CALCULUS URINARY 1 0.0006
170 NEPHROGENIC ANAEMIA 3 0.0006
171 MEGACOLON 1 0.0006
172 GASTROINTESTINAL STOMA COMPLICATION 1 0.0006
173 INCORRECT DOSE ADMINISTERED BY PRODUCT 1 0.0006
174 SHOULDER FRACTURE 1 0.0006
175 POLYP 4 0.0006
176 STAPHYLOCOCCAL SEPSIS 3 0.0006
177 ILLUSION 1 0.0006
178 MALIGNANT PLEURAL EFFUSION 1 0.0006
179 BILIARY DYSKINESIA 1 0.0006
180 LOWER RESPIRATORY TRACT CONGESTION 1 0.0006
181 INCORRECT STORAGE OF DRUG 1 0.0006
182 DEVICE DEFECTIVE 10 0.0006
183 SLEEP APNOEA SYNDROME 11 0.0006
184 PRODUCT CONTAINER SEAL ISSUE 1 0.0006
185 BURNS SECOND DEGREE 1 0.0006
186 POLYMYOSITIS 1 0.0006
187 INDURATION 1 0.0006
188 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
189 APPLICATION SITE DISCOMFORT 1 0.0006
190 PNEUMONIA KLEBSIELLA 1 0.0005
191 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
192 VITRITIS 1 0.0005
193 BLADDER SPASM 1 0.0005
194 CYSTOID MACULAR OEDEMA 1 0.0005
195 HEPATIC MASS 1 0.0005
196 PATENT DUCTUS ARTERIOSUS 2 0.0005
197 APPLICATION SITE PAIN 11 0.0005
198 CARDIAC DISCOMFORT 1 0.0005
199 VITAMIN B12 DEFICIENCY 2 0.0005
200 EYELID PAIN 1 0.0005
201 SPINA BIFIDA 1 0.0005
202 ATRIAL TACHYCARDIA 1 0.0005
203 INTESTINAL STENOSIS 2 0.0005
204 NEUROGENIC BLADDER 1 0.0005
205 CANDIDA INFECTION 8 0.0005
206 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
207 AORTIC VALVE INCOMPETENCE 2 0.0005
208 DEVICE DIFFICULT TO USE 31 0.0005
209 RECTAL HAEMORRHAGE 20 0.0005
210 VITREOUS DETACHMENT 1 0.0005
211 RENAL TUBULAR ACIDOSIS 1 0.0005
212 CHOLECYSTITIS CHRONIC 3 0.0004
213 CALCINOSIS 1 0.0004
214 PRODUCT LABEL ISSUE 3 0.0004
215 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
216 HAEMATOCRIT INCREASED 1 0.0004
217 CYTOMEGALOVIRUS COLITIS 1 0.0004
218 APHTHOUS STOMATITIS 1 0.0004
219 DEFAECATION URGENCY 3 0.0004
220 BILIRUBIN CONJUGATED INCREASED 1 0.0004
221 DYSPNOEA EXERTIONAL 16 0.0004
222 SINUS OPERATION 1 0.0004
223 RADIUS FRACTURE 1 0.0004
224 HAEMATOLOGICAL INFECTION 1 0.0004
225 CHRONIC KIDNEY DISEASE 31 0.0004
226 APPLICATION SITE BURN 2 0.0004
227 SUFFOCATION FEELING 1 0.0004
228 DEVICE ISSUE 36 0.0004
229 VENTRICULAR HYPERTROPHY 1 0.0004
230 DRUG LEVEL DECREASED 4 0.0004
231 AORTIC ARTERIOSCLEROSIS 1 0.0004
232 BLOOD CHLORIDE DECREASED 1 0.0004
233 VENTRICULAR DYSFUNCTION 1 0.0004
234 ACTINIC KERATOSIS 1 0.0004
235 PERSONALITY DISORDER 1 0.0004
236 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1 0.0004
237 INCORRECT DOSE ADMINISTERED BY DEVICE 10 0.0004
238 PRODUCT USE COMPLAINT 6 0.0004
239 COLITIS ULCERATIVE 17 0.0004
240 LUNG OPACITY 1 0.0004
241 ANAL FISTULA 2 0.0004
242 TEMPOROMANDIBULAR JOINT SYNDROME 1 0.0004
243 ANAL FISSURE 2 0.0004
244 ANAL ABSCESS 2 0.0004
245 ABDOMINAL RIGIDITY 1 0.0004
246 TOOTH FRACTURE 4 0.0004
247 RED BLOOD CELL COUNT INCREASED 1 0.0004
248 PLEURITIC PAIN 1 0.0004
249 PRODUCT PHYSICAL CONSISTENCY ISSUE 2 0.0004
250 DIABETIC COMA 1 0.0004
251 ANAL HAEMORRHAGE 1 0.0004
252 JOINT LOCK 1 0.0004
253 OESOPHAGEAL STENOSIS 1 0.0004
254 VENTRICULAR SEPTAL DEFECT 2 0.0003
255 SPEECH DISORDER DEVELOPMENTAL 1 0.0003
256 FIBULA FRACTURE 1 0.0003
257 TOOTH DISCOLOURATION 1 0.0003
258 CATARACT OPERATION 2 0.0003
259 FREQUENT BOWEL MOVEMENTS 9 0.0003
260 TENSION 2 0.0003
261 DUODENITIS 1 0.0003
262 INTRACARDIAC THROMBUS 1 0.0003
263 BRAIN DEATH 1 0.0003
264 TALIPES 1 0.0003
265 INJECTION SITE HYPERSENSITIVITY 1 0.0003
266 ABDOMINAL ADHESIONS 1 0.0003
267 HEPATIC NEOPLASM 1 0.0003
268 DEAFNESS NEUROSENSORY 1 0.0003
269 TOOTH INFECTION 4 0.0003
270 EXPIRED DEVICE USED 1 0.0003
271 FUNGAL INFECTION 10 0.0003
272 PLANTAR FASCIITIS 1 0.0003
273 WOUND DEHISCENCE 1 0.0003
274 APPLICATION SITE DRYNESS 1 0.0003
275 COLITIS 11 0.0003
276 HAEMATOCHEZIA 16 0.0003
277 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
278 DEPRESSION SUICIDAL 1 0.0003
279 LARGE INTESTINE POLYP 2 0.0003
280 MUSCLE CONTRACTIONS INVOLUNTARY 1 0.0003
281 NECROTISING FASCIITIS 1 0.0003
282 HEART DISEASE CONGENITAL 1 0.0003
283 FIBRIN D DIMER INCREASED 1 0.0003
284 HAEMORRHAGIC DIATHESIS 1 0.0003
285 RED BLOOD CELL COUNT DECREASED 8 0.0003
286 FREEZING PHENOMENON 1 0.0003
287 ORAL PAIN 6 0.0003
288 OSTEOPOROSIS 11 0.0003
289 SNORING 1 0.0003
290 GASTRIC INFECTION 1 0.0003
291 DEVICE PHYSICAL PROPERTY ISSUE 2 0.0003
292 OSTEOARTHRITIS 11 0.0003
293 THERAPEUTIC PRODUCT INEFFECTIVE 1 0.0003
294 BURNING SENSATION 18 0.0003
295 ORAL INFECTION 1 0.0003
296 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
297 BLOOD IRON DECREASED 3 0.0003
298 PRODUCT PRESCRIBING ERROR 6 0.0003
299 BLEPHARITIS 1 0.0002
300 INTRACRANIAL ANEURYSM 1 0.0002
301 ENURESIS 1 0.0002
302 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
303 DECUBITUS ULCER 2 0.0002
304 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
305 GASTROINTESTINAL PERFORATION 1 0.0002
306 CONGESTIVE CARDIOMYOPATHY 1 0.0002
307 BUNDLE BRANCH BLOCK LEFT 1 0.0002
308 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
309 LUNG NEOPLASM 1 0.0002
310 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
311 ALCOHOLISM 1 0.0002
312 TENSION HEADACHE 1 0.0002
313 CHAPPED LIPS 1 0.0002
314 DEVICE USE ISSUE 4 0.0002
315 CATHETERISATION CARDIAC 1 0.0002
316 WHEELCHAIR USER 1 0.0002
317 RHINITIS ALLERGIC 1 0.0002
318 FACIAL PAIN 2 0.0002
319 GASTROOESOPHAGEAL REFLUX DISEASE 18 0.0002
320 VASCULAR DEVICE INFECTION 1 0.0002
321 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
322 HAEMOGLOBIN INCREASED 1 0.0002
323 DEVICE MECHANICAL ISSUE 3 0.0002
324 DRUG LEVEL ABOVE THERAPEUTIC 1 0.0002
325 PNEUMONIA BACTERIAL 2 0.0002
326 DYSPAREUNIA 1 0.0002
327 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
328 NEPHROPATHY 2 0.0002
329 FLANK PAIN 2 0.0002
330 TIBIA FRACTURE 1 0.0002
331 DEVICE OCCLUSION 3 0.0002
332 SQUAMOUS CELL CARCINOMA 2 0.0002
333 SKIN ABRASION 1 0.0002
334 FOOT FRACTURE 4 0.0002
335 PRE-ECLAMPSIA 1 0.0002
336 GESTATIONAL DIABETES 1 0.0002
337 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
338 HYPOVOLAEMIC SHOCK 1 0.0002
339 IMPAIRED QUALITY OF LIFE 3 0.0002
340 FAECAL INCONTINENCE 1 0.0002
341 ACUTE RESPIRATORY FAILURE 4 0.0002
342 APHAGIA 1 0.0002
343 VULVOVAGINAL PAIN 1 0.0002
344 VITAMIN D DEFICIENCY 2 0.0002
345 COELIAC DISEASE 2 0.0002
346 PANCREATIC DISORDER 1 0.0002
347 RENAL INJURY 6 0.0002
348 INFLAMMATORY MARKER INCREASED 1 0.0002
349 DEEP VEIN THROMBOSIS 13 0.0002
350 CYTOKINE RELEASE SYNDROME 4 0.0002
351 PRODUCT DOSE OMISSION 13 0.0002
352 PRODUCT PHYSICAL ISSUE 4 0.0002
353 ECONOMIC PROBLEM 3 0.0002
354 LOWER RESPIRATORY TRACT INFECTION 9 0.0002
355 PATHOLOGICAL FRACTURE 1 0.0002
356 NEUTROPHIL COUNT INCREASED 2 0.0002
357 PRODUCT COLOUR ISSUE 1 0.0002
358 PERIPHERAL VASCULAR DISORDER 1 0.0002
359 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
360 HYPERBILIRUBINAEMIA 2 0.0002
361 FAILURE TO THRIVE 1 0.0002
362 SENSITIVITY TO WEATHER CHANGE 1 0.0002
363 BLOOD LACTIC ACID INCREASED 1 0.0002
364 INCONTINENCE 2 0.0002
365 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
366 OVERWEIGHT 1 0.0002
367 WHEEZING 11 0.0002
368 BRUXISM 1 0.0002
369 DECREASED ACTIVITY 2 0.0002
370 STRESS FRACTURE 1 0.0002
371 BIPOLAR DISORDER 2 0.0002
372 PRODUCT PRESCRIBING ISSUE 4 0.0002
373 MULTIPLE FRACTURES 3 0.0002
374 PROSTATIC DISORDER 1 0.0002
375 HYPERKERATOSIS 1 0.0002
376 HYPERTENSIVE CRISIS 2 0.0002
377 STREPTOCOCCAL INFECTION 1 0.0002
378 SKIN INFECTION 2 0.0002
379 FISTULA 2 0.0002
380 OFF LABEL USE 155 0.0002
381 SKIN TOXICITY 1 0.0002
382 MITRAL VALVE INCOMPETENCE 2 0.0002
383 CHOLECYSTECTOMY 2 0.0002
384 PARANOIA 3 0.0002
385 NEOPLASM 2 0.0002
386 HERPES VIRUS INFECTION 1 0.0002
387 HYPERVENTILATION 1 0.0002
388 EYELID OEDEMA 2 0.0002
389 ECZEMA 9 0.0002
390 URINE ODOUR ABNORMAL 1 0.0002
391 PULMONARY EMBOLISM 16 0.0002
392 DISEASE RECURRENCE 8 0.0002
393 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 34 0.0002
394 TYPE 1 DIABETES MELLITUS 1 0.0002
395 INGUINAL HERNIA 1 0.0002
396 VULVOVAGINAL BURNING SENSATION 1 0.0002
397 MUSCLE SPASTICITY 2 0.0002
398 CYST 2 0.0002
399 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
400 MULTIPLE INJURIES 1 0.0002
401 GASTRIC ULCER 3 0.0002
402 MYDRIASIS 2 0.0002
403 ROTATOR CUFF SYNDROME 2 0.0002
404 POOR QUALITY DRUG ADMINISTERED 1 0.0002
405 INCOHERENT 1 0.0002
406 NEPHROLITHIASIS 7 0.0002
407 SOMNAMBULISM 1 0.0002
408 ANHEDONIA 4 0.0002
409 WALKING AID USER 1 0.0002
410 PRODUCT FORMULATION ISSUE 1 0.0002
411 SARS-COV-2 TEST POSITIVE 2 0.0002
412 DYSMENORRHOEA 2 0.0002
413 POST-TRAUMATIC STRESS DISORDER 1 0.0001
414 TACHYPNOEA 2 0.0001
415 CROHN'S DISEASE 1 0.0001
416 TOOTH LOSS 3 0.0001
417 PRODUCT USE ISSUE 27 0.0001
418 RENAL FAILURE 19 0.0001
419 RIGHT VENTRICULAR FAILURE 1 0.0001
420 DIALYSIS 2 0.0001
421 SINUS TACHYCARDIA 2 0.0001
422 PARAESTHESIA ORAL 2 0.0001
423 PANIC REACTION 1 0.0001
424 DERMATITIS BULLOUS 1 0.0001
425 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
426 INTENTIONAL UNDERDOSE 1 0.0001
427 MAJOR DEPRESSION 1 0.0001
428 HYPOPHOSPHATAEMIA 1 0.0001
429 ARTHROPOD BITE 1 0.0001
430 HYDRONEPHROSIS 1 0.0001
431 INCORRECT DOSE ADMINISTERED 30 0.0001
432 ACIDOSIS 1 0.0001
433 DISSOCIATION 1 0.0001
434 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
435 CONGENITAL ANOMALY 1 0.0001
436 HYPOALBUMINAEMIA 1 0.0001
437 APNOEA 1 0.0001
438 PELVIC FRACTURE 1 0.0001
439 DEVICE MALFUNCTION 9 0.0001
440 GASTROINTESTINAL INFLAMMATION 1 0.0001
441 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
442 RENAL CYST 1 0.0001
443 BLOOD PRESSURE FLUCTUATION 3 0.0001
444 RHINITIS 1 0.0001
445 STENT PLACEMENT 1 0.0001
446 MYASTHENIA GRAVIS 1 0.0001
447 OEDEMA PERIPHERAL 15 0.0001
448 ENCEPHALOPATHY 3 0.0001
449 ABNORMAL FAECES 1 0.0001
450 HICCUPS 1 0.0001
451 HAIR DISORDER 1 0.0001
452 SPINAL COMPRESSION FRACTURE 1 0.0001
453 GASTROINTESTINAL HAEMORRHAGE 10 0.0001
454 LIVE BIRTH 1 0.0001
455 ATRIAL SEPTAL DEFECT 1 0.0001
456 ABDOMINAL PAIN LOWER 3 0.0001
457 UTERINE PERFORATION 1 0.0001
458 CIRCULATORY COLLAPSE 2 0.0001
459 VITAMIN D DECREASED 1 0.0001
460 SCAR 2 0.0001
461 SKIN HYPERPIGMENTATION 1 0.0001
462 INFLAMMATION 6 0.0001
463 CARDIAC MURMUR 1 0.0001
464 SKIN SWELLING 1 0.0001
465 DISCOMFORT 7 0.0001
466 URINE OUTPUT DECREASED 1 0.0001
467 NAIL DISORDER 1 0.0001
468 GASTRITIS 3 0.0001
469 HEART RATE DECREASED 4 0.0001
470 GROIN PAIN 1 0.0001
471 PANCREATITIS 6 0.0001
472 COLD SWEAT 2 0.0001
473 IMMUNOSUPPRESSION 1 0.0001
474 MYOSITIS 1 0.0001
475 ANAL INCONTINENCE 1 0.0001
476 BLOOD BILIRUBIN INCREASED 3 0.0001
477 DEVELOPMENTAL DELAY 1 0.0001
478 LEUKOCYTOSIS 2 0.0001
479 LIMB INJURY 3 0.0001
480 OPTIC NEURITIS 1 0.0001
481 END STAGE RENAL DISEASE 2 0.0001
482 HIDRADENITIS 1 0.0001
483 EXOSTOSIS 1 0.0001
484 NERVE COMPRESSION 1 0.0001
485 DEFORMITY 1 0.0001
486 DIARRHOEA HAEMORRHAGIC 1 0.0001
487 PHOTOPHOBIA 2 0.0001
488 ARTERIOSCLEROSIS 1 0.0001
489 INTESTINAL OBSTRUCTION 4 0.0001
490 ACUTE KIDNEY INJURY 16 0.0001
491 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
492 GLAUCOMA 2 0.0001
493 ATELECTASIS 1 0.0001
494 INTENTIONAL PRODUCT MISUSE 9 0.0001
495 INTENTIONAL PRODUCT USE ISSUE 9 0.0001
496 HEPATIC ENZYME INCREASED 7 0.0001
497 INFLAMMATORY BOWEL DISEASE 1 0.0001
498 PHARYNGEAL SWELLING 1 0.0001
499 RENAL TUBULAR NECROSIS 1 0.0001
500 ARTHRITIS 8 0.0001
501 HOSPICE CARE 1 0.0001
502 SINUS DISORDER 2 0.0001
503 SYNCOPE 10 0.0001
504 PREGNANCY 2 0.0001
505 SPINAL FRACTURE 2 0.0001
506 BRAIN INJURY 1 0.0001
507 PREMATURE BABY 3 0.0001
508 PERITONITIS BACTERIAL 1 0.0001
509 CORONARY ARTERY DISEASE 3 0.0001
510 STOMATITIS 6 0.0001
511 DEVICE BREAKAGE 4 0.0001
512 DRY THROAT 1 0.0001
513 SLUGGISHNESS 1 0.0001
514 SINUSITIS 10 0.0001
515 TEMPERATURE INTOLERANCE 1 0.0001
516 FEMUR FRACTURE 3 0.0001
517 POOR VENOUS ACCESS 1 0.0001
518 VENTRICULAR EXTRASYSTOLES 1 0.0001
519 SWOLLEN TONGUE 3 0.0001
520 WEIGHT FLUCTUATION 1 0.0001
521 PRODUCT ODOUR ABNORMAL 1 0.0001
522 TRANSFUSION 1 0.0001
523 FOLLICULITIS 1 0.0001
524 INJECTION SITE DISCOMFORT 1 0.0001
525 JOINT DISLOCATION 1 0.0001
526 RETCHING 2 0.0001
527 BREAST PAIN 1 0.0001
528 SKIN CANCER 2 0.0001
529 SKIN LACERATION 1 0.0001
530 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
531 GASTROINTESTINAL PAIN 1 0.0001
532 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
533 SKIN DISORDER 3 0.0001
534 MATERNAL EXPOSURE DURING PREGNANCY 8 0.0001
535 MALNUTRITION 1 0.0001
536 INTESTINAL PERFORATION 1 0.0001
537 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 16 0.0001
538 EYE INFECTION 1 0.0001
539 STATUS EPILEPTICUS 1 0.0001
540 CHEST DISCOMFORT 9 0.0001
541 PRODUCT AVAILABILITY ISSUE 2 0.0001
542 OROPHARYNGEAL PAIN 8 0.0001
543 MADAROSIS 1 0.0001
544 ELECTROLYTE IMBALANCE 1 0.0001
545 CONDITION AGGRAVATED 26 0.0001
546 COVID-19 PNEUMONIA 1 0.0001
547 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
548 BACTERAEMIA 1 0.0001
549 CHOLECYSTITIS 1 0.0001
550 HYPERLIPIDAEMIA 1 0.0001
551 DIABETIC KETOACIDOSIS 2 0.0001
552 CRYING 3 0.0001
553 ADRENAL INSUFFICIENCY 1 0.0001
554 HYPERGLYCAEMIA 3 0.0001
555 NO THERAPEUTIC RESPONSE 1 0.0001
556 FEELING HOT 5 0.0001
557 CARDIOMEGALY 1 0.0001
558 SMALL INTESTINAL OBSTRUCTION 1 0.0001
559 TENDON RUPTURE 1 0.0001
560 GENERALISED OEDEMA 1 0.0001
561 APPLICATION SITE IRRITATION 1 0.0001
562 HAIR COLOUR CHANGES 1 0.0001
563 ASTHMA 9 0.0001
564 GASTRIC CANCER 2 0.0001
565 HYPOPHAGIA 2 0.0001
566 PAIN 48 0.0001
567 HAEMOGLOBIN DECREASED 8 0.0001
568 ILLNESS 8 0.0001
569 INJECTION SITE INDURATION 1 0.0001
570 PLATELET COUNT INCREASED 1 0.0001
571 JOINT STIFFNESS 2 0.0001
572 PULMONARY CONGESTION 1 0.0001
573 ADVERSE REACTION 1 0.0001
574 DEHYDRATION 10 0.0001
575 COUGH 21 0.0001
576 HAIR TEXTURE ABNORMAL 1 0.0001
577 QUALITY OF LIFE DECREASED 1 0.0001
578 SINUS CONGESTION 1 0.0001
579 ANXIETY 21 0.0001
580 PNEUMONITIS 2 0.0001
581 IMPAIRED GASTRIC EMPTYING 1 0.0001
582 GINGIVAL BLEEDING 1 0.0001
583 SKIN LESION 2 0.0001
584 APPLICATION SITE RASH 1 0.0001
585 DIVERTICULITIS 2 0.0001
586 PROCEDURAL PAIN 2 0.0001
587 MENTAL STATUS CHANGES 2 0.0001
588 ORAL DISCOMFORT 1 0.0001
589 HYPOMAGNESAEMIA 1 0.0001
590 CARDIO-RESPIRATORY ARREST 3 0.0001
591 COORDINATION ABNORMAL 1 0.0001
592 APHONIA 1 0.0001
593 WOUND 2 0.0001
594 WEIGHT INCREASED 16 0.0001
595 CARPAL TUNNEL SYNDROME 1 0.0001
596 OXYGEN SATURATION DECREASED 4 0.0001
597 INJURY 5 0.0001
598 SKIN REACTION 1 0.0001
599 FLATULENCE 4 0.0001
600 INTENTIONAL DOSE OMISSION 2 0.0001
601 SUBDURAL HAEMATOMA 1 0.0001
602 PARALYSIS 1 0.0001
603 MYELODYSPLASTIC SYNDROME 1 0.0001
604 ANOSMIA 1 0.0001
605 FLUID OVERLOAD 1 0.0001
606 GASTROENTERITIS 1 0.0001
607 SURGERY 4 0.0001
608 ACUTE MYOCARDIAL INFARCTION 2 0.0001
609 TACHYCARDIA 6 0.0001
610 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
611 PULMONARY MASS 1 0.0001
612 ABDOMINAL DISTENSION 7 0.0001
613 HAEMORRHAGE 7 0.0001
614 DIARRHOEA 43 0.0001
615 BONE LOSS 1 0.0001
616 HYPOAESTHESIA ORAL 1 0.0001
617 LACRIMATION INCREASED 2 0.0001
618 OSTEOPENIA 1 0.0001
619 DEVICE FAILURE 1 0.0001
620 DRUG DISPENSING ERROR 1 0.0001
621 DEVICE RELATED INFECTION 1 0.0001
622 PRODUCT DOSE OMISSION ISSUE 19 0.0001
623 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 3 0.0001
624 ACUTE MYELOID LEUKAEMIA 1 0.0001
625 BASAL CELL CARCINOMA 1 0.0001
626 BONE DENSITY DECREASED 2 0.0001
627 BRAIN FOG 1 0.0001
628 CYANOSIS 1 0.0001
629 PNEUMOTHORAX 1 0.0001
630 ULCER 1 0.0001
631 OBESITY 1 0.0001
632 ABSCESS 1 0.0001
633 THROMBOSIS 5 0.0001
634 RHINORRHOEA 4 0.0001
635 BLOOD POTASSIUM INCREASED 1 0.0001
636 INFLUENZA LIKE ILLNESS 5 0.0001
637 STAPHYLOCOCCAL INFECTION 2 0.0001
638 GENERAL PHYSICAL HEALTH DETERIORATION 7 0.0001
639 HYPOAESTHESIA 9 0.0001
640 DRY EYE 3 0.0001
641 COAGULOPATHY 1 0.0001
642 HYPOTENSION 12 0.0001
643 CELLULITIS 3 0.0001
644 TYPE 2 DIABETES MELLITUS 2 0.0001
645 HYPERSENSITIVITY 11 0.0001
646 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
647 FLUID RETENTION 3 0.0001
648 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
649 DRUG EXPOSURE DURING PREGNANCY 2 0.0001
650 URINARY TRACT INFECTION 10 0.0001
651 HAEMATURIA 2 0.0001
652 GASTRIC DISORDER 2 0.0001
653 MULTI-ORGAN FAILURE 1 0.0001
654 EMOTIONAL DISTRESS 7 0.0001
655 NIGHTMARE 2 0.0001
656 ANAEMIA 11 0.0001
657 ORTHOSTATIC HYPOTENSION 1 0.0001
658 LOCAL SWELLING 1 0.0001
659 RASH MACULAR 2 0.0001
660 HYPOXIA 2 0.0001
661 DEPRESSED MOOD 3 0.0001
662 LYMPHOCYTE COUNT DECREASED 1 0.0001
663 HEAD DISCOMFORT 1 0.0001
664 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
665 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
666 DRUG ERUPTION 1 0.0001
667 INSOMNIA 15 0.0001
668 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 4 0.0001
669 ISCHAEMIC STROKE 1 0.0001
670 GASTROINTESTINAL DISORDER 5 0.0001
671 MOBILITY DECREASED 4 0.0001
672 ADVERSE DRUG REACTION 5 0.0001
673 PELVIC PAIN 1 0.0001
674 RESTLESS LEGS SYNDROME 1 0.0001
675 PANIC ATTACK 2 0.0001
676 UNDERDOSE 4 0.0001
677 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
678 MUSCLE SPASMS 10 0.0001
679 NASOPHARYNGITIS 10 0.0001
680 HEPATIC STEATOSIS 1 0.0001
681 ABDOMINAL PAIN UPPER 11 0.0001
682 HEPATIC CIRRHOSIS 1 0.0001
683 EYE PAIN 3 0.0001
684 DYSARTHRIA 2 0.0001
685 BLOOD SODIUM DECREASED 1 0.0001
686 NEUROPATHY PERIPHERAL 5 0.0001
687 MUSCULOSKELETAL DISORDER 1 0.0001
688 FEELING JITTERY 1 0.0001
689 MIGRAINE 5 0.0001
690 HERPES ZOSTER 3 0.0001
691 LETHARGY 3 0.0001
692 PULMONARY FIBROSIS 1 0.0001
693 PRODUCT SUBSTITUTION ISSUE 3 0.0001
694 DRUG PRESCRIBING ERROR 1 0.0001
695 HERNIA 1 0.0001
696 ABDOMINAL PAIN 12 0.0001
697 EAR PAIN 1 0.0001
698 SKIN FISSURES 1 0.0001
699 DRUG DOSE OMISSION BY DEVICE 4 0.0001
700 NASAL CONGESTION 3 0.0001
701 DRUG INEFFECTIVE 67 0.0001
702 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
703 DISORIENTATION 2 0.0001
704 CONSTIPATION 11 0.0001
705 HAEMATOCRIT DECREASED 1 0.0001
706 CATARACT 3 0.0001
707 BLOOD PRESSURE ABNORMAL 1 0.0001
708 IRRITABILITY 3 0.0000
709 CARDIAC FAILURE CONGESTIVE 4 0.0000
710 FULL BLOOD COUNT DECREASED 1 0.0000
711 INTENTIONAL SELF-INJURY 1 0.0000
712 PRODUCT ADMINISTRATION ERROR 1 0.0000
713 NEUTROPHIL COUNT DECREASED 2 0.0000
714 BODY TEMPERATURE INCREASED 1 0.0000
715 PERITONITIS 1 0.0000
716 PULMONARY HYPERTENSION 1 0.0000
717 DERMATITIS 1 0.0000
718 RENAL FAILURE ACUTE 2 0.0000
719 IRRITABLE BOWEL SYNDROME 1 0.0000
720 HYPERHIDROSIS 6 0.0000
721 POOR QUALITY SLEEP 1 0.0000
722 SWELLING FACE 3 0.0000
723 SEPTIC SHOCK 2 0.0000
724 MENTAL DISORDER 2 0.0000
725 PRODUCT STORAGE ERROR 4 0.0000
726 HOSPITALISATION 7 0.0000
727 BLOOD PRESSURE DECREASED 3 0.0000
728 STEVENS-JOHNSON SYNDROME 1 0.0000
729 TRANSAMINASES INCREASED 1 0.0000
730 TOOTH DISORDER 1 0.0000
731 SEPSIS 5 0.0000
732 RASH PAPULAR 1 0.0000
733 SNEEZING 1 0.0000
734 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
735 PRODUCT USE IN UNAPPROVED INDICATION 11 0.0000
736 APPLICATION SITE PRURITUS 1 0.0000
737 DEPRESSION 10 0.0000
738 ERYTHEMA 9 0.0000
739 SKIN IRRITATION 2 0.0000
740 TINNITUS 2 0.0000
741 SKIN DISCOLOURATION 2 0.0000
742 MUSCLE TWITCHING 1 0.0000
743 CONFUSIONAL STATE 7 0.0000
744 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
745 PERICARDIAL EFFUSION 1 0.0000
746 RENAL DISORDER 2 0.0000
747 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
748 CARDIAC DISORDER 4 0.0000
749 SWELLING 4 0.0000
750 CHILLS 5 0.0000
751 VOMITING 20 0.0000
752 SLEEP DISORDER 3 0.0000
753 ARRHYTHMIA 2 0.0000
754 OCULAR HYPERAEMIA 2 0.0000
755 ABDOMINAL DISCOMFORT 7 0.0000
756 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
757 FIBROMYALGIA 1 0.0000
758 PRESYNCOPE 1 0.0000
759 ATRIAL FIBRILLATION 4 0.0000
760 ARTHRALGIA 17 0.0000
761 AGITATION 3 0.0000
762 DYSPNOEA 23 0.0000
763 BRONCHITIS 3 0.0000
764 HEART RATE INCREASED 4 0.0000
765 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
766 AGEUSIA 1 0.0000
767 COVID-19 7 0.0000
768 HOT FLUSH 3 0.0000
769 CARDIOVASCULAR DISORDER 1 0.0000
770 DIABETES MELLITUS 3 0.0000
771 INJECTION SITE SWELLING 3 0.0000
772 UNRESPONSIVE TO STIMULI 1 0.0000
773 RASH GENERALISED 1 0.0000
774 HAEMATOMA 1 0.0000
775 RESPIRATORY TRACT INFECTION 1 0.0000
776 NERVOUSNESS 2 0.0000
777 NAUSEA 30 0.0000
778 HYPERTENSION 8 0.0000
779 BRADYCARDIA 2 0.0000
780 JAUNDICE 1 0.0000
781 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
782 MOOD ALTERED 1 0.0000
783 DRUG DOSE OMISSION 6 0.0000
784 RESPIRATORY DISTRESS 1 0.0000
785 ABNORMAL DREAMS 1 0.0000
786 FALL 12 0.0000
787 FEELING COLD 1 0.0000
788 PANCYTOPENIA 2 0.0000
789 THROMBOCYTOPENIA 4 0.0000
790 BLISTER 2 0.0000
791 PAIN IN JAW 1 0.0000
792 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
793 HYPERSOMNIA 1 0.0000
794 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
795 PANCREATIC CARCINOMA 1 0.0000
796 DECREASED APPETITE 8 0.0000
797 BACK PAIN 8 0.0000
798 RASH 15 0.0000
799 MALAISE 15 0.0000
800 DYSPHONIA 2 0.0000
801 ASCITES 1 0.0000
802 PSYCHOTIC DISORDER 1 0.0000
803 RESPIRATORY DISORDER 1 0.0000
804 VERTIGO 2 0.0000
805 SUICIDAL IDEATION 3 0.0000
806 INJECTION SITE RASH 1 0.0000
807 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
808 EMOTIONAL DISORDER 1 0.0000
809 LIMB DISCOMFORT 1 0.0000
810 WEIGHT DECREASED 9 0.0000
811 EXPOSURE DURING PREGNANCY 2 0.0000
812 PYREXIA 11 0.0000
813 HEAD INJURY 1 0.0000
814 MOOD SWINGS 1 0.0000
815 GAIT DISTURBANCE 6 0.0000
816 METABOLIC ACIDOSIS 1 0.0000
817 CONTUSION 3 0.0000
818 MOVEMENT DISORDER 1 0.0000
819 HIP FRACTURE 1 0.0000
820 NIGHT SWEATS 1 0.0000
821 LACTIC ACIDOSIS 1 0.0000
822 DYSPEPSIA 3 0.0000
823 IMPAIRED HEALING 1 0.0000
824 OSTEONECROSIS 1 0.0000
825 EYE DISORDER 1 0.0000
826 TREMOR 5 0.0000
827 EXPIRED PRODUCT ADMINISTERED 1 0.0000
828 VIRAL INFECTION 1 0.0000
829 LIP SWELLING 1 0.0000
830 URINARY RETENTION 1 0.0000
831 NEOPLASM MALIGNANT 2 0.0000
832 INJECTION SITE PRURITUS 2 0.0000
833 EYE PRURITUS 1 0.0000
834 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
835 NEUTROPENIA 4 0.0000
836 VISION BLURRED 4 0.0000
837 DELIRIUM 1 0.0000
838 NEOPLASM PROGRESSION 1 0.0000
839 HYPERKALAEMIA 1 0.0000
840 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
841 PLATELET COUNT DECREASED 3 0.0000
842 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
843 INFECTION 4 0.0000
844 NO ADVERSE EVENT 5 0.0000
845 DRUG EFFECT INCOMPLETE 1 0.0000
846 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
847 RESPIRATORY FAILURE 2 0.0000
848 ACCIDENTAL OVERDOSE 1 0.0000
849 DYSURIA 1 0.0000
850 PAIN IN EXTREMITY 8 0.0000
851 INJECTION SITE MASS 1 0.0000
852 INFLUENZA 3 0.0000
853 HALLUCINATION 2 0.0000
854 PRURITUS 10 0.0000
855 SEIZURE 3 0.0000
856 PERIPHERAL SWELLING 4 0.0000
857 FATIGUE 20 0.0000
858 ALOPECIA 5 0.0000
859 DISEASE PROGRESSION 3 0.0000
860 FEELING ABNORMAL 6 0.0000
861 CARDIAC FAILURE 2 0.0000
862 PNEUMONIA 8 0.0000
863 INJECTION SITE ERYTHEMA 3 0.0000
864 DIZZINESS 12 0.0000
865 RHABDOMYOLYSIS 1 0.0000
866 POLLAKIURIA 1 0.0000
867 ASTHENIA 9 0.0000
868 WITHDRAWAL SYNDROME 1 0.0000
869 RENAL IMPAIRMENT 2 0.0000
870 SKIN EXFOLIATION 2 0.0000
871 MYALGIA 4 0.0000
872 DEVICE DISLOCATION 1 0.0000
873 PULMONARY OEDEMA 1 0.0000
874 THERAPY NON-RESPONDER 1 0.0000
875 HYPOKALAEMIA 1 0.0000
876 RASH ERYTHEMATOUS 1 0.0000
877 MULTIPLE SCLEROSIS 1 0.0000
878 BLOOD GLUCOSE DECREASED 1 0.0000
879 HEADACHE 13 0.0000
880 LUNG DISORDER 1 0.0000
881 AGGRESSION 1 0.0000
882 BLOOD PRESSURE INCREASED 3 0.0000
883 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
884 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
885 MUSCULOSKELETAL PAIN 1 0.0000
886 PARAESTHESIA 3 0.0000
887 DERMATITIS ATOPIC 1 0.0000
888 DRUG DEPENDENCE 3 0.0000
889 RASH PRURITIC 1 0.0000
890 TREATMENT NONCOMPLIANCE 1 0.0000
891 ARTHROPATHY 1 0.0000
892 NECK PAIN 1 0.0000
893 HYPONATRAEMIA 1 0.0000
894 MUSCULAR WEAKNESS 2 0.0000
895 MYOCARDIAL INFARCTION 3 0.0000
896 BONE PAIN 1 0.0000
897 JOINT SWELLING 2 0.0000
898 THERAPEUTIC RESPONSE DECREASED 1 0.0000
899 SUICIDE ATTEMPT 1 0.0000
900 PLEURAL EFFUSION 1 0.0000
901 CHEST PAIN 3 0.0000
902 AMNESIA 1 0.0000
903 BLOOD CREATININE INCREASED 1 0.0000
904 PSORIASIS 2 0.0000
905 FEBRILE NEUTROPENIA 1 0.0000
906 DRY SKIN 2 0.0000
907 SOMNOLENCE 3 0.0000
908 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
909 MEMORY IMPAIRMENT 2 0.0000
910 INJECTION SITE REACTION 1 0.0000
911 THERAPY INTERRUPTED 1 0.0000
912 SKIN BURNING SENSATION 1 0.0000
913 OVERDOSE 3 0.0000
914 EPISTAXIS 1 0.0000
915 UNEVALUABLE EVENT 1 0.0000
916 ACNE 1 0.0000
917 INJECTION SITE BRUISING 1 0.0000
918 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
919 CARDIAC ARREST 1 0.0000
920 DRUG ABUSE 1 0.0000
921 COMPLETED SUICIDE 1 0.0000
922 URTICARIA 2 0.0000
923 BALANCE DISORDER 1 0.0000
924 MUSCULOSKELETAL STIFFNESS 1 0.0000
925 DRUG WITHDRAWAL SYNDROME 1 0.0000
926 ADVERSE EVENT 1 0.0000
927 BLOOD GLUCOSE INCREASED 2 0.0000
928 DYSPHAGIA 1 0.0000
929 DRUG INTOLERANCE 1 0.0000
930 FLUSHING 1 0.0000
931 INJECTION SITE PAIN 3 0.0000
932 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
933 RHEUMATOID ARTHRITIS 1 0.0000
934 PALPITATIONS 1 0.0000
935 DEATH 7 0.0000
936 LOSS OF CONSCIOUSNESS 1 0.0000
937 DRUG INTERACTION 1 0.0000
938 CEREBROVASCULAR ACCIDENT 1 0.0000